Salivary Gland Toxicity of PSMA Radioligand Therapy: Relevance and Preventive Strategies-Reference-Cited by-同舟云学术

Salivary Gland Toxicity of PSMA Radioligand Therapy: Relevance and Preventive Strategies

Published:2018-06-14 Issue:8 Volume:59 Page:1172-1173
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Langbein Thomas,Chaussé Guillaume,Baum Richard P.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference18 articles.

1. Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy

2. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control

3. 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy

4. German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

5. Functional imaging of the salivary glands for evaluation of radiation-induced sialadenitis before and after Lu-177 PSMA radioligand therapy [abstract];Langbein;Eur J Nucl Med Mol Imaging.,2017

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automated preparation of Actinium-225 with accelerator-based production from irradiated natural thorium targets;Separation and Purification Technology;2025-02

2. Prostate-specific Membrane Antigen: Alpha-labeled Radiopharmaceuticals;PET Clinics;2024-07

3. Discovery of Glutamate Carboxypeptidase III Ligands to Compete the Uptake of [¹⁷⁷Lu]Lu-PSMA-617 in Healthy Organs;Journal of Medicinal Chemistry;2024-05-08

4. Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?;Pharmaceuticals;2024-04-16

5. Molecular radionuclide therapy-induced salivary gland toxicity: an unappreciated threat to patients’ quality of life?;Nuclear Medicine Communications;2024-04-05